Other languages Immix Biopharma, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 12:54:53 2025-12-10 pm EST			5-day change	1st Jan Change
6.655 ^USD	+0.83%		+58.31%	+198.64%

Dec. 07	Immix Biopharma prices offering of 19.1 million shares at $5.10 per share	RE
Nov. 12	Immix Biopharma, Inc. Appoints Michael Grabow as Chief Commercial Officer	CI

La FDA approuve le dossier d’essai clinique de Immix Biopharma CAR-T NXC-201, et en permet ainsi l’administration aux patients américains	23-11-22
Immix Biopharma gibt die FDA-Genehmigung des IND-Antrags für CAR-T NXC-201 bekannt, der die Verabreichung an US-Patienten ermöglicht	23-11-22

No results for this search